These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35917564)

  • 1. Identification of the Binding Epitope of an Anti-mouse CCR4 Monoclonal Antibody, C
    Asano T; Suzuki H; Tanaka T; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Aug; 41(4):214-220. PubMed ID: 35917564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Novel Anti-Mouse CCR4 Monoclonal Antibody (C
    Takei J; Suzuki H; Asano T; Tanaka T; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):87-93. PubMed ID: 35471046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
    Ajram L; Begg M; Slack R; Cryan J; Hall D; Hodgson S; Ford A; Barnes A; Swieboda D; Mousnier A; Solari R
    Eur J Pharmacol; 2014 Apr; 729(100):75-85. PubMed ID: 24534492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
    Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
    Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL22-specific Antibodies Reveal That Engagement of Two Distinct Binding Domains on CCL22 Is Required for CCR4-mediated Function.
    Santulli-Marotto S; Wheeler J; Lacy ER; Boakye K; Luongo J; Wu SJ; Ryan M
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):373-80. PubMed ID: 26683175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
    Bonecchi R; Locati M; Galliera E; Vulcano M; Sironi M; Fra AM; Gobbi M; Vecchi A; Sozzani S; Haribabu B; Van Damme J; Mantovani A
    J Immunol; 2004 Apr; 172(8):4972-6. PubMed ID: 15067078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
    Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
    J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
    Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP priming of macrophage-derived chemokine responses in CHO cells expressing the CCR4 receptor.
    Rosethorne EM; Leighton-Davies JR; Beer D; Charlton SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):64-70. PubMed ID: 15167983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
    Scheu S; Ali S; Ruland C; Arolt V; Alferink J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
    Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
    Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
    Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
    J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope Mapping of an Anti-Human CCR9 Monoclonal Antibody (C
    Takei J; Asano T; Li G; Saito M; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Dec; 40(6):239-242. PubMed ID: 34958276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
    Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
    J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
    Shimauchi T; Imai S; Hino R; Tokura Y
    Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice.
    Jakubzick C; Wen H; Matsukawa A; Keller M; Kunkel SL; Hogaboam CM
    Am J Pathol; 2004 Oct; 165(4):1211-21. PubMed ID: 15466387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice.
    Nakagami Y; Kawashima K; Yonekubo K; Etori M; Jojima T; Miyazaki S; Sawamura R; Hirahara K; Nara F; Yamashita M
    Eur J Pharmacol; 2009 Dec; 624(1-3):38-44. PubMed ID: 19818758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope Mapping of an Anti-elephant Podoplanin Monoclonal Antibody (PMab-295) Using Enzyme-Linked Immunosorbent Assay.
    Okada Y; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Aug; 41(4):221-227. PubMed ID: 35917553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CCL22 levels decreased in parallel with disease activity in CCR4-positive mycosis fungoides treated with mogamulizumab.
    Ohuchi K; Fujimura T; Lyu C; Amagai R; Muto Y; Aiba S
    Dermatol Ther; 2020 Nov; 33(6):e14099. PubMed ID: 32725764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR4 and its ligands: from bench to bedside.
    Yoshie O; Matsushima K
    Int Immunol; 2015 Jan; 27(1):11-20. PubMed ID: 25087232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.